focus on shock
TRANSCRIPT
![Page 1: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/1.jpg)
Focus on Shock
(Relates to Chapter 67, “Nursing Management: Shock and Multiple Organ Dysfunction Syndrome,” in the textbook)
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 2: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/2.jpg)
2
Shock
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 3: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/3.jpg)
3
Shock
Classification of shock
Cardiogenic HypovolemicDistributiveObstructive
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 4: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/4.jpg)
4
Low Blood FlowCardiogenic Shock Definition:
Systolic or diastolic dysfunction Compromised cardiac output (CO)
Precipitating causes: MI Cardiomyopathy Blunt cardiac injury Severe systemic or pulmonary hypertension Cardiac Tamponade Myocardial depression from metabolic
problems Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 5: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/5.jpg)
Pathophysiology of Cardiogenic Shock
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 5
Fig. 67-1. Relationship of shock, systemic inflammatory response syndrome, and multiple
organ dysfunction syndrome. CNS, Central nervous system.
![Page 6: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/6.jpg)
6
Low Blood FlowCardiogenic Shock
Early manifestations TachycardiaHypotensionNarrowed pulse pressure ↑ myocardial O2 consumption
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 7: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/7.jpg)
7
Low Blood FlowCardiogenic Shock
Physical examination Tachypnea, pulmonary congestion Pallor; cool, clammy skinDecreased capillary refill timeAnxiety, confusion, agitation
↑ in pulmonary artery wedge pressure Decreased renal perfusion and UO
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 8: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/8.jpg)
8
Low Blood FlowHypovolemic Shock
Absolute hypovolemia: Loss of intravascular fluid volume
HemorrhageGI loss (e.g., vomiting, diarrhea) Fistula drainageDiabetes insipidusHyperglycemiaDiuresis
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 9: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/9.jpg)
9
Low Blood FlowHypovolemic Shock
Relative hypovolemia fluid volume moves out of the vascular
space into extravascular space (e.g., interstitial or intracavitary space)
Termed third spacing
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 10: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/10.jpg)
Pathophysiology of Hypovolemic Shock
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 10
Fig. 67-3. The pathophysiology of hypovolemic shock.
![Page 11: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/11.jpg)
11
Low Blood FlowHypovolemic Shock
Body response to acute volume loss depends on :
Extent of injury or insultAgeGeneral state of health
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 12: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/12.jpg)
12
Low Blood FlowHypovolemic Shock
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 13: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/13.jpg)
13
Distributive ShockNeurogenic Shock
Hemodynamic phenomenon that can occur within 30 minutes of a spinal cord injury at the fifth thoracic (T5) vertebra or above and can last up to 6 weeks
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 14: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/14.jpg)
14
Distributive ShockNeurogenic Shock
Can occur in response to spinal anesthesia Results in massive vasodilation,
leading to pooling of blood in vessels
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 15: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/15.jpg)
Pathophysiology of Neurogenic Shock
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 15
Fig. 67-4. The pathophysiology of neurogenic shock. BP, Blood pressure.
![Page 16: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/16.jpg)
16
Distributive ShockNeurogenic Shock
Clinical manifestations HypotensionBradycardia Temperature dysregulation (resulting
in heat loss)Dry skin Poikilothermia (taking on the
temperature of the environment)
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 17: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/17.jpg)
17
Distributive ShockAnaphylactic Shock
Acute, life-threatening hypersensitivity reactionMassive vasodilationRelease of mediators ↑ capillary permeability
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 18: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/18.jpg)
18
Distributive ShockAnaphylactic Shock
Clinical manifestationsAnxiety, confusion, dizziness Sense of impending doom Chest pain Incontinence
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 19: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/19.jpg)
19
Distributive ShockAnaphylactic Shock
Clinical manifestations Swelling of the lips and tongue,
angioedemaWheezing, stridor Flushing, pruritus, urticariaRespiratory distress and circulatory
failure
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 20: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/20.jpg)
20
Distributive ShockSeptic Shock
Sepsis: systemic inflammatory response to documented or suspected infection
Severe sepsis = Sepsis + Organ dysfunction
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 21: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/21.jpg)
21
Distributive ShockSeptic Shock
Septic shock = Presence of sepsis with hypotension
despite fluid resuscitation Presence of tissue perfusion
abnormalities
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 22: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/22.jpg)
Pathophysiology of Septic Shock
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 22
Fig. 67-5. The pathophysiology of septic shock. CNS, Central nervous system.
![Page 23: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/23.jpg)
23Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 24: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/24.jpg)
24
Distributive ShockSeptic Shock
Clinical manifestations ↑ coagulation and inflammation ↓ fibrinolysis
Formation of microthrombi Obstruction of microvasculature
Hyperdynamic state: increased CO and decreased SVR
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 25: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/25.jpg)
25
Distributive ShockSeptic Shock
Clinical manifestations (cont’d) Tachypnea/hyperventilation Temperature dysregulation ↓ urine outputAltered neurologic statusGI dysfunctionRespiratory failure is common.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 26: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/26.jpg)
26
Obstructive Shock
Develops when physical obstruction to blood flow occurs with decreased CO From restriction to diastolic filling of
the right ventricle due to compressionAbdominal compartment syndrome
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 27: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/27.jpg)
27
Obstructive Shock
Patient will experienceDecreased CO Increased afterloadVariable left ventricular filling
pressures
Rapid assessment and immediate treatment are important.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 28: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/28.jpg)
28
Stages of Shock1. Initial Stage
Usually not clinically apparentMetabolism changes from aerobic to
anaerobic. Lactic acid accumulates and must be
removed by blood and broken down by liver.
Process requires unavailable O2.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 29: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/29.jpg)
29
Stages of Shock2. Compensatory Stage
Clinically apparent NeuralHormonalBiochemical compensatory
mechanisms
Attempts are aimed at overcoming consequences of anaerobic metabolism and maintaining homeostasis.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 30: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/30.jpg)
Compensatory Stage of Shock
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 30
Fig. 67-7. Compensatory stage: reversible stage during which compensatory mechanisms are
effective and homeostasis is maintained.
![Page 31: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/31.jpg)
31
Stages of Shock2. Compensatory Stage
Baroreceptors in carotid and aortic bodies activate SNS in response to ↓BP.Vasoconstriction while blood to vital
organs maintained
↓ blood to kidneys activates renin–angiotensin system ↑ venous return to heart, CO, BP
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 32: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/32.jpg)
32
Stages of Shock2. Compensatory Stage
Impaired GI motilityRisk for paralytic ileus
Cool, clammy skin from blood Except septic patient who is warm and
flushed
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 33: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/33.jpg)
33
Stages of Shock2. Compensatory Stage
Shunting blood from lungs increases physiologic dead space.
↓ arterial O2 levels Increase in rate/depth of respirations V/Q mismatch
SNS stimulation increases myocardial O2 demands.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 34: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/34.jpg)
34
Stages of Shock2. Compensatory Stage
If perfusion deficit corrected, patient recovers with no residual sequelae
If deficit not corrected, patient enters progressive stage
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 35: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/35.jpg)
35
Stages of Shock3. Progressive Stage
Begins when compensatory mechanisms fail
Aggressive interventions to prevent multiple organ dysfunction syndrome
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 36: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/36.jpg)
Progressive Stage of Shock
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 36
Fig. 67-8. Progressive stage: compensatory mechanisms are becoming ineffective and
fail to maintain perfusion to vital organs.
![Page 37: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/37.jpg)
37
Stages of Shock3. Progressive Stage
Hallmarks of ↓ cellular perfusion and altered capillary permeability
Leakage of protein into interstitial space ↑ systemic interstitial edema
Anasarca Fluid leakage affects solid organs and
peripheral tissues. ↓ blood flow to pulmonary capillaries
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 38: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/38.jpg)
38
Stages of Shock3. Progressive Stage
Movement of fluid from pulmonary vasculature to interstitium
Pulmonary edema Bronchoconstriction ↓ residual capacity
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 39: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/39.jpg)
39
Stages of Shock3. Progressive Stage
Fluid moves into alveoli Edema Decreased surfactant Worsening V/Q mismatch Tachypnea Crackles Increased work of breathing
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 40: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/40.jpg)
40
Stages of Shock3. Progressive Stage
CO begins to fall Decreased peripheral perfusion Hypotension Weak peripheral pulses Ischemia of distal extremities
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 41: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/41.jpg)
41
Stages of Shock3. Progressive Stage
Myocardial dysfunction results in Dysrhythmias Ischemia Myocardial infarction End result: complete deterioration of
cardiovascular system
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 42: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/42.jpg)
42
Stages of Shock3. Progressive Stage
Mucosal barrier of GI system becomes ischemic
Ulcers Bleeding Risk of translocation of bacteria Decreased ability to absorb nutrients
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 43: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/43.jpg)
43
Stages of Shock3. Progressive Stage
Liver fails to metabolize drugs and waste.
Jaundice Elevated enzymes Loss of immune function Risk for DIC and significant bleeding
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 44: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/44.jpg)
44
Stages of Shock4. Irreversible Stage
Exacerbation of anaerobic metabolism Accumulation of lactic acid ↑ capillary permeability
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 45: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/45.jpg)
Irreversible Stage of Shock
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. 45
Fig. 67-9. Irreversible or refractory stage: compensatory mechanisms are not functioning or are
totally ineffective, leading to multiple organ dysfunction syndrome.
![Page 46: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/46.jpg)
46
Stages of Shock4. Irreversible Stage
Profound hypotension and hypoxemia Tachycardia worsens. Failure of one organ system affects
others. Recovery unlikely
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 47: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/47.jpg)
47
Diagnostic Studies
Thorough history and physical examination No single study to determine shock
Blood studies Elevation of lactate Base deficit
12-lead ECG Chest x-rayHemodynamic monitoring
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 48: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/48.jpg)
48
Collaborative Care
Identify patients at risk Integration of the patient’s history, physical
examination, and clinical findings to establish a diagnosis
Interventions to control or eliminate the cause of decreased perfusion
Protection of target and distal organs from dysfunction
Provision of multisystem supportive care
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 49: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/49.jpg)
49
Collaborative Care
General strategies Ensure patent airway.Maximize oxygen delivery.
Cornerstone of therapy for septic, hypovolemic, and anaphylactic shock = Volume expansion* Isotonic crystalloids (e.g., normal
saline) for initial resuscitation of shock
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 50: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/50.jpg)
50Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 51: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/51.jpg)
51
Collaborative Care
Volume expansion If the patient does not respond to 2 to
3 L of crystalloids, then blood administration and central venous monitoring may be instituted.
Complications of fluid resuscitation Hypothermia
Coagulopathy
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 52: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/52.jpg)
52
Collaborative Care
Primary goal of drug therapy = Correction of decreased tissue perfusion Vasopressor drugs (e.g., norepinephrine)
Achieve/maintain MAP >60 to 65 mm Hg. Reserved for patients unresponsive to fluid
resuscitation
Vasodilator therapy (e.g., nitroglycerin, nitroprusside) Achieve/maintain MAP >65 mm Hg.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 53: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/53.jpg)
53
Collaborative Care
Nutrition: vital to decreasing morbidity
from shock.
Initiate enteral nutrition within the first 24 hours.
Initiate parenteral nutrition if enteral feedings contraindicated or fail to meet at least 80% of caloric requirements
Monitor protein, nitrogen balance, BUN, glucose, electrolytes.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 54: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/54.jpg)
54
Collaborative CareCardiogenic Shock
Restore blood flow to the myocardium by restoring the balance between O2supply & demand.
Thrombolytic therapy Angioplasty with stenting Emergency revascularization Valve replacement
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 55: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/55.jpg)
55
Collaborative CareCardiogenic Shock
Hemodynamic monitoring Drug therapy (e.g., diuretics to
reduce preload) Circulatory assist devices (e.g.,
intraaortic balloon pump, ventricular assist device)
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 56: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/56.jpg)
56
Collaborative CareHypovolemic Shock
Management focuses on stoppingthe loss of fluid and restoring the circulating volume.
Fluid replacement is calculated using a 3:1 rule: (3 mL of isotonic crystalloid for every 1
mL of estimated blood loss).
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 57: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/57.jpg)
57
Collaborative CareSeptic Shock
Fluid replacement to restore perfusion Hemodynamic monitoring
Vasopressor drug therapy
Vasopressin for patients refractory to vasopressor therapy
IV corticosteroids if failed vasopressor therapy & fluid resuscitation, to maintain adequate BP
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 58: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/58.jpg)
58
Collaborative Care Septic Shock
Antibiotics after cultures are obtained (e.g., blood, wound exudate, urine, stool, sputum)
Drotrecogin alfa (Xigris)Major side effect: bleeding
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 59: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/59.jpg)
59
Collaborative Care Septic Shock
Glucose levels <150 mg/dL Stress ulcer prophylaxis with
histamine (H2)-receptor blockers Deep vein thrombosis prophylaxis
with low-dose unfractionated heparin or low-molecular-weight heparin
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 60: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/60.jpg)
60
Collaborative CareNeurogenic Shock
In spinal cord injury: spinal stability
Tx hypotension and bradycardia with vasopressors and atropine
Fluids cautiouslyMonitor for hypothermia.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 61: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/61.jpg)
61
Collaborative CareAnaphylactic Shock
Epinephrine, diphenhydramine Maintaining a patent airway
Nebulized bronchodilators Endotracheal intubation or
cricothyroidotomy may be necessary Aggressive fluid replacement Intravenous corticosteroids if significant
hypotension persists after 1 to 2 hours of aggressive therapy
.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 62: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/62.jpg)
62
Collaborative CareObstructive Shock
Early recognition and treatment is primary strategy.Mechanical decompression Radiation or removal of mass Decompressive laparotomy
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 63: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/63.jpg)
63
Nursing Assessment
ABCs: airway, breathing, and circulation
Focused assessment of tissue perfusion Vital signs Peripheral pulses Level of consciousness Capillary refill Skin (e.g., temperature, color, moisture) Urine output
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 64: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/64.jpg)
64
Nursing Assessment
Brief history Events leading to shockOnset and duration of symptoms
Details of care received before hospitalization Allergies Vaccinations
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 65: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/65.jpg)
65
Nursing Diagnoses
Ineffective tissue perfusion: renal, cerebral, cardiopulmonary, gastrointestinal, hepatic, and peripheral Fear Potential complication: organ
ischemia/dysfunction
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 66: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/66.jpg)
66
Planning
Goals for patientAssurance of adequate tissue perfusionRestoration of normal or baseline BPReturn/recovery of organ functionAvoidance of complications from
prolonged states of hypoperfusion
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 67: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/67.jpg)
67
Nursing Implementation
Health promotion Identify patients at risk.
Elderly patients Those with debilitating illness Those who are immunocompromised Surgical or accidental trauma patients
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 68: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/68.jpg)
68
Nursing Implementation
Health promotion (cont’d)
Planning to prevent shock Monitoring fluid balance to prevent
hypovolemic shock Maintenance of hand washing to prevent
spread of infection
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 69: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/69.jpg)
69
Nursing Implementation
Neurologic status: orientation and level of consciousness Cardiac status
Continuous ECG VS, capillary refillHemodynamic parameters: central
venous pressure, PA pressures, CO, PAWP
Heart sounds: murmurs, S3, S4
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 70: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/70.jpg)
70
Nursing Implementation
Respiratory status Respiratory rate and rhythmBreath sounds Continuous pulse oximetry Arterial blood gases Most patients will be intubated and
mechanically ventilated.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 71: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/71.jpg)
71
Nursing Implementation
Urine output Tympanic or pulmonary arterial
temperature Skin: temperature, pallor, flushing,
cyanosis, diaphoresis, piloerection Bowel sounds
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 72: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/72.jpg)
72
Nursing Implementation
Nasogastric drainage/stools for occult blood I&O, fluid and electrolyte balance Oral care/hygiene based on O2
requirements Passive/active range of motion
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 73: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/73.jpg)
73
Nursing Implementation
Assess level of anxiety and fear.Medication PRN Talk to patientVisit from clergy Family involvement Comfort measures Privacy Call light within reach
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 74: Focus on Shock](https://reader033.vdocuments.net/reader033/viewer/2022051306/6279454b5abcf46c543befc1/html5/thumbnails/74.jpg)
74
Evaluation
Normal or baseline, ECG, BP, CVP, and PAWP Normal temperatureWarm, dry skin Urinary output >0.5 mL/kg/hr Normal RR and SaO2 ≥90% Verbalization of fears, anxiety
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.